Isofol Medical Management
Management criteria checks 0/4
Isofol Medical's CEO is Petter Lindqvist, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.04% of the company’s shares, worth SEK157.13K. The average tenure of the management team and the board of directors is 0.9 years and 0.9 years respectively.
Key information
Petter Lindqvist
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.04% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
We're Interested To See How Isofol Medical (STO:ISOFOL) Uses Its Cash Hoard To Grow
Jul 12
An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued
May 18Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation
Nov 09Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?
May 12Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)
Apr 08Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment
Mar 03We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully
Jan 10
CEO
Petter Lindqvist
less than a year
Tenure
Mr. Petter Segelman Lindqvist serves as Chief Executive Officer of Isofol Medical AB (publ) since January 09, 2024. He served as Chief Executive Officer of Hamlet BioPharma AB (publ) (formerly known as Ham...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | no data | 0.040% SEK 157.1k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
0.9yrs
Average Tenure
Experienced Management: ISOFOL's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | less than a year | SEK 996.00k | 0.40% SEK 1.5m | |
| Independent Director | less than a year | no data | 0.0019% SEK 7.5k | |
| Independent Director | less than a year | SEK 29.00k | 0.25% SEK 979.7k | |
| Independent Director | less than a year | SEK 271.00k | no data | |
| Independent Director | less than a year | no data | no data |
0.9yrs
Average Tenure
77.5yo
Average Age
Experienced Board: ISOFOL's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 05:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Isofol Medical AB (publ) is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ulrik Trattner | Carnegie Investment Bank AB |
| Ole-Andreas Krohn | DNB Markets |
| David Martinsson | DNB Markets |